Successful Closing of a Seed Funding

 

Theobald Associates is pleased to announce the successful closing of a seed funding for its client, Ikarovec Limited. The transaction raised approximately £2,500,000 from leading start up investors UKI2S, Lifearc and Parkwalk. The Company intends to use the funds to develop novel gene therapies to treat major ophthalmic indications. Further details can be found at: https://ikarovec.com/ikarovec-completes-2-5-million-seed-funding-round/